Babesia sp. EU1 Infection in a Forest Reindeer, the Netherlands by Kik, Marja et al.
LETTERS
This work was supported by grants 
from the Ministry of Science and 
Technology, China (2003BA712A08-01; 
2008ZX10004-001; 2011CB504702); 
China–US CDC Cooperative Agreement 
U19-GH000004; and Development Grant 
of State Key Laboratory for Infectious 
Disease Prevention and Control 
(2008SKLID105).
Yi-Xing Li,1 Ming-Hua Li,1 
Shi-Hong Fu, Wei-Xin Chen, 
Qi-Yong Liu, Hai-Lin Zhang, Wa 
Da, Song-Lin Hu, 
Sang Dan La Mu, Ju Bai, 
Zun-Dong Yin, Hong-Yue Jiang, 
Yu-Hong Guo, Dun Zhu Duo Ji, 
Hui-Mei Xu, Ge Li, 
Gu Gu Cuo Mu, Hui-Ming Luo, 
Jing-Lin Wang, Jun Wang, 
Xiu-Min Ye, Zhuo Ma Yang Jin, 
Wei Zhang, Gui-Jun Ning, 
Huan-Yu Wang, Gui-Chang Li, 
Jian Yong, Xiao-Feng Liang, 
and Guo-Dong Liang
Author affi liations: National Immunization 
Programme, Chinese Center for Disease 
Control and Prevention, Beijing, People’s 
Republic of China (Y.-X. Li, Z.-D. Yin, H.-
M. Luo, G.-J. Ning, X.-F. Liang); Institute 
for Viral Disease Control and Prevention, 
Beijing (M.-H. Li, S.-H. Fu, W.-X. Chen, 
H.-Y. Jiang, J.-L. Wang, H.-Y. Wang, G.-D. 
Liang); National Institute for Communicable 
Disease Control and Prevention, Beijing 
(Q.-Y. Liu, Y.-H. Guo, J. Wang, G.-C. Li); 
Yunnan Institute of Endemic Disease 
Control and Prevention, Yunnan, People’s 
Republic of China (H.-L. Zhang); Tibet 
Center for Disease Control and Prevention, 
Tibet, People’s Republic of China (W. Da, 
D.Z.D. Ji, X.-M. Ye); Nyingchi Center for 
Disease Control and Prevention, Tibet (S.-
L. Hu, H.-M. Xu, Z.M.Y. Jin); Medog County 
Center for Disease Control and Prevention, 
Tibet, (S.D.L. Mu, G. Li, W. Zhang, J. Yong); 
Mainling County Center for Disease Control 
and Prevention, Tibet (J. Bai, G.G.C. Mu) 
DOI: 10.3201/eid1705.101417
1These authors contributed equally to this 
article.
References
  1.  International Travel and Health. Infectious 
diseases of potential risk for travelers. Ge-
neva: World Health Organization; 2010.
  2.  Brunette GW, Kozarsky PE, Magill AJ, 
Shlim DR. The pre-travel consultation. In: 
CDC health information for international 
travel, 2010 (the yellow book). New York: 
Elsevier; 2009. p. 19–241.
  3.  Gao X, Nasci R, Liang G. The neglected 
arboviral infections in mainland Chi-
na. PLoS Negl Trop Dis. 2010;4:e624. 
doi:10.1371/journal.pntd.0000624
  4.  Wang H, Li Y, Liang X, Liang G. Japanese 
encephalitis in mainland China. Jpn J In-
fect Dis. 2009;62:331–6.
  5.  Wang LH, Fu SH, Wang HY, Liang GD, 
Cheng JX, Jing HM, et al. Japanese en-
cephalitis outbreak, Yuncheng, China, 
2006. Emerg Infect Dis. 2007;13:1123–5.
  6. Solomon T, Ni H, Beasley DW, Ekkelen-
kamp M, Cardosa MJ, Barrett AD. 
Origin and evolution of Japanese en-
cephalitis virus in southeast Asia. J 
Virol. 2003;77:3091–8. doi:10.1128/
JVI.77.5.3091-3098.2003
  7.  Kuniholm MH, Wolfe ND, Huang CY, 
Mpoudi-Ngole E, Tamoufe U, LeBreton 
M, et al. Seroprevalence and distribution 
of Flaviviridae, Togaviridae, and Bunya-
viridae arboviral infections in rural Cam-
eroonian adults. [Erratum in: Am J Trop 
Med Hyg. 2006;75:371]. Am J Trop Med 
Hyg. 2006;74:1078–83.
  8.  Halstead SB. Japanese encephalitis. In: 
Artenstein AW, editor. Vaccines: a biogra-
phy. New York: Springer; 2010. p. 317–
34.
  9.  Cardosa MJ, Hah FL, Choo BH, Padma-
nathan S. Screening of pig sera for anti-
bodies to Japanese encephalitis virus us-
ing a dot enzyme immunoassay and IgM 
capture ELISA: comparison with the hem-
agglutination inhibition and plaque reduc-
tion neutralization tests. Southeast Asian J 
Trop Med Public Health. 1993;24:472–6.
10.  Erlanger TE, Weiss S, Keiser J, Utzinger 
J, Wiedenmayer K. Past, present, and 
future of Japanese encephalitis. Emerg 
Infect Dis. 2009;15:1–7. doi:10.3201/
eid1501.080311
Address for correspondence: Guo-Dong 
Liang, State Key Laboratory for Infectious 
Disease Prevention and Control, Institute for 
Viral Disease Control and Prevention, Chinese 
Center for Disease Control and Prevention, 100 
Yingxin St., Xuanwu District, Beijing 100052, 
People’s Republic of China; email: gdliang@
hotmail.com
Babesia sp. EU1 
Infection in a 
Forest Reindeer, 
the Netherlands
To the Editor: Fatal piroplasmosis 
in domestic reindeer (Rangifer spp.) 
was fi rst reported by Kertzelli in 1909; 
he named the piroplasm Piroplasma 
tarandi rhangferis. Similar piroplasms 
also were observed in blood smears of 
reindeer that had a condition known as 
spleen disease, which occurred in the 
second part of summer in the Arctic 
tundra and was characterized by 
clinical signs such as splenomegaly, 
icterus, pale mucous membranes, 
and death (1). Hemoglobinuria, a 
characteristic sign of babesiosis, is not 
mentioned in these early 20th century 
reports. However, these signs were 
observed in a Babesia divergens–
infected reindeer herd in Scotland (2).
The only other reported cases 
of severe babesiosis in reindeer and 
caribou (Rangifer tarandus caribou) 
were caused by B. odocoilei, a 
predominantly nonpathogenic parasite 
of white-tailed deer (Odocoileus 
virginianus) that can cause fatal 
infection in reindeer (3,4). Babesia 
sp. EU1 is a recently recognized 
zoonotic Babesia species that has been 
associated with human babesiosis in 
Europe and is phylogenetically related 
to the B. odocoilei parasite (5). We 
report on a juvenile reindeer with 
babesiosis caused by Babesia sp. EU1.
A 5-week-old, captive-bred, 
female forest reindeer from an 
otherwise healthy herd of 9 animals 
in a zoo in the Netherlands was 
euthanized after showing clinical 
signs of lethargy, jaundice, and 
hemorrhagic diarrhea for >8 hours 
that did not improve after treatment 
with butylscopolamine (Buscopan; 
Boehringer Ingelheim, Alkmaar, 
the Netherlands) and enrofl oxacin 
(Baytril; Bayer, Leverkusen, 
Germany). At necropsy, jaundice 
was evident in the sclera, aorta, and 
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leptomeninges. On the basis of the 
degree of fat storage and muscle 
development, the body condition was 
fair. The lungs were hyperemic and 
edematous, and the trachea contained 
foam. The liver was enlarged and pale; 
the spleen was enlarged. The kidneys 
were dark brown. Hemoglobinuria 
was noted in the urinary bladder.
Tissue samples from various 
organs were in fi xed in 4% phosphate-
buffered formalin, embedded in 
paraffi n, cut into 4-μm sections, 
and stained with hematoxylin and 
eosin. No microscopic lesions were 
found in the skin, thymus, thyroid 
gland, tonsils, salivary glands, 
tongue, gastrointestinal tract, or 
heart. Numerous hemosiderin-laden 
macrophages were found in the spleen 
and liver sinusoids. Pigmentary 
nephrosis with moderate tubular 
degeneration and focal interstitial 
petechial hemorrhages were seen in 
the kidneys. Erythrophagocytosis 
was evident in the mesenteric lymph 
nodes, liver, and spleen.
Cytologic analysis was performed 
on samples from the brain, liver, spleen, 
lungs, and large intestinal contents, 
which were stained with Hemacolor 
(Merck, Darmstadt, Germany). Large 
(2–3 μm), intraerythrocytic protozoal 
inclusions consistent with Babesia 
spp. (Figure) were identifi ed in the 
liver, spleen, lung, and brain.
DNA was extracted from 200 
μL blood and ≈25 mg of the tissues 
collected during the necropsy: bone 
marrow, brain, heart, kidney, liver, 
lung, lymph node, small intestinal 
wall, and spleen. All extractions 
were performed by using the 
Nucleospin Tissue Kit (Macherey-
Nagel, Düren, Germany) according 
to the manufacturer’s protocol. The 
detection of PCR products by reverse 
line blot hybridization was performed 
as described (6). All blood and tissue 
samples from each organ tested were 
positive only for Babesia sp. EU1.
To confi rm these results, primers 
18SAN and 18SBN were used to 
amplify a 1,705-bp fragment of the 
18S rRNA gene (7), the fragment 
was subsequently purifi ed, cloned 
into the pGEM-T Easy Vector 
(Promega, Leiden, the Netherlands), 
and sequenced (Baseclear, Leiden, 
the Netherlands). The resulting 
sequence (GenBank accession no. 
GQ888709) was 100% identical to 
that of Babesia sp. EU1 isolated from 
human babesiosis patients from Italy 
and Austria (GenBank accession no. 
AY046575). In an attempt to identify 
subclinical carriers of this piroplasm, 
blood samples from the reindeer’s 
mother and another nonrelated calf 
from the herd were collected and 
tested by reverse line blot, but test 
results for both animals were negative.
These fi ndings make trans-
placental transmission as a route 
of infection less likely and favor 
the bite of an infected tick as the 
cause of disease. Babesia sp. EU1 is 
transmitted by Ixodes ricinus ticks 
(8), which are widespread in cool 
humid areas of Europe. Of I. ricinus 
ticks from the Netherlands, ≈1% are 
infected with Babesia sp. EU1 (6). 
The only confi rmed reservoir host of 
Babesia sp. EU1 is roe deer (Capreolus 
capreolus) (9). The infected forest 
reindeer resided in a zoo in an area 
without direct contact with roe deer, 
although roe deer are abundant in the 
forests surrounding the zoo.
Because Babesia sp. EU1 can 
be transmitted both transovarially 
and transstadially (10), the infection 
source may have been the offspring of 
a tick infected in a previous generation 
or an immature tick that fed on 
infected roe deer outside the zoo or 
an as yet unidentifi ed reservoir host 
and was carried into the reindeer’s 
compound by hosts, such as birds or 
small rodents. Babesia sp. EU1 is the 
third Babesia spp. to be recognized 
as the cause of fatal babesiosis in 
reindeer, together with B. divergens 
and B. odocoilei.
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Figure. Lung of a forest reindeer infected with Babesia sp. EU1. Arrows indicate erythrocytes 
with protozoal inclusions. Scale bar = 20 μm.
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To the Editor: In July 2010, 
dengue virus serotype 4 (DENV-
4) reemerged in Boa Vista, the 
capital of Roraima State, in northern 
Brazil (Figure, panel A), after an 
absence of 28 years (1). Cases were 
identifi ed during late June in the 
municipalities of Boa Vista and Cantá. 
For all patients, the clinical course of 
disease was classic, and all recovered 
uneventfully. The most commonly 
reported signs and symptoms were 
fever, headache, chills, muscle and 
joint pains, rash, nausea and vomiting, 
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Figure. A) Boa Vista, Roraima State, Brazil, showing the districts where dengue virus 
type 4 (DENV-4) was isolated. 1, Liberdade; 2, Buritis; 3, Cauamé; 4, Santa Tereza; 5, 
Cidade Satélite; 6, Dr. Silvio Leite; 7, Joquel Clube; 8, Sen. Hélio Campos. B) Phylogenetic 
analysis of the DENV-4 envelope gene sequences (in boldface) constructed by using the 
neighbor-joining method, showing the cluster formed by Boa Vista and Venenzuela DENV-
4 genotype I strains. Bootstrap values were set for 1,000 replicates and are placed over 
each main node of the tree. ROR1982 represents the DENV-4 isolated in Roraima State 
during the 1982 epidemic. A to B1–B4 represent genotype I subclades. Thailand 1978 
and Thailand 1985 strains represent the Asian genotype II. Scale bar corresponds to 1% 
nucleotide sequence divergence.
